# T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

> **NCT00048464** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xcyte Therapies** · enrollment: 35 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Infusion of Activated & Expanded Autologous T Cells

## Key facts

- **NCT ID:** NCT00048464
- **Lead sponsor:** Xcyte Therapies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 35 (—)
- **Last updated:** 2006-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048464, "T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00048464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*